Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $241.2 million.

  • Roivant Sciences' Net Cash Flow rose 10530.06% to $241.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2 billion, marking a year-over-year increase of 8634.17%. This contributed to the annual value of -$3.8 billion for FY2025, which is 17875.17% down from last year.
  • Per Roivant Sciences' latest filing, its Net Cash Flow stood at $241.2 million for Q4 2025, which was up 10530.06% from -$2.7 million recorded in Q3 2025.
  • Roivant Sciences' Net Cash Flow's 5-year high stood at $5.0 billion during Q4 2023, with a 5-year trough of -$4.6 billion in Q4 2024.
  • In the last 5 years, Roivant Sciences' Net Cash Flow had a median value of -$133.3 million in 2021 and averaged -$408.7 million.
  • As far as peak fluctuations go, Roivant Sciences' Net Cash Flow soared by 103656.66% in 2023, and later crashed by 1457437.42% in 2024.
  • Quarter analysis of 5 years shows Roivant Sciences' Net Cash Flow stood at $84.5 million in 2021, then tumbled by 731.07% to -$533.0 million in 2022, then surged by 1036.57% to $5.0 billion in 2023, then tumbled by 191.15% to -$4.6 billion in 2024, then soared by 105.3% to $241.2 million in 2025.
  • Its last three reported values are $241.2 million in Q4 2025, -$2.7 million for Q3 2025, and -$1.5 billion during Q2 2025.